Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leptin Treatment During Weight Loss
NCT00050791Phase 2Completed
- Sponsor
- The Rockefeller University
- Start
- Mar 2001
- Primary completion
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing VLCD and leptin with placebo (2 arms). Primary endpoint: Energy Expenditure. Started Mar 2001; status: completed.
02
Drugs
metreleptin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00050791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050791.